Vertex Pharmaceuticals Incorporated (VRTX) stock prices updated...
 

Vertex Pharmaceuticals Incorporated stock price

Vertex Pharmaceuticals Incorporated latest news:


  • 12/12/2017 09:41:14

    BRIEF-Vertex, CRISPR Therapeutics To Co-Develop CTX001 As CRISPR/Cas9 Gene Edited Treatment

    Vertex Pharmaceuticals Inc(VRTX): * VERTEX AND CRISPR THERAPEUTICS TO CO-DEVELOP AND CO-COMMERCIALIZE CTX001 AS CRISPR/CAS9 GENE EDITED TREATMENT FOR SICKLE CELL DISEASE AND Β-THALASSEMIA. * Vertex Pharmaceuticals Inc (VRTX) - VERTEX SELECTS CTX001 AS FIRST GENE EDITED TREATMENT TO BE DEVELOPED AS PART OF COLLABORATION WITH CRISPR THERAPEUTICS.

  • More trends:

    Vestin Realty Mortgage I, Inc.VRTA | Vestin Realty Mortgage II, Inc.VRTB | Viacom Inc.VIA | Viacom Inc.VIAB | ViaSat, Inc.VSAT | Viavi Solutions Inc.VIAV | Vical IncorporatedVICL | Vicor CorporationVICR | Vident Core U.S. Bond Strategy FundVBND | Vident Core US Equity ETFVUSE |